Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

12. Januar 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1902


	Artikel 1 - 20 / 38026

	Development of a predictive model for lymph node metastasis in esophageal cancer using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) semi-quantitative parameters and tumor biomarkers. J Gastrointest Oncol Li N, Huang M, Bao W, Ding C, Mao X. PMID: 41522764 [PubMed - in process]
	Survival analysis of small cell carcinoma of the esophagus: a 15-year retrospective study from a high-incidence region. J Gastrointest Oncol Zhang W, Yuan J, Yang B, Wang J, Chen M. PMID: 41522760 [PubMed - in process]
	Prognostic value of left gastric artery lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma: a retrospective cohort study. J Thorac Dis Yang P, Shi P, Yang T, Liu T, Zhang J, Zhu B, Li Y. PMID: 41522127 [PubMed]
	Association of perioperative cholesterol depletion with anastomotic leak after esophagectomy for cancer: a retrospective study. J Thorac Dis Liu M, He S, Zhou E, Ren B. PMID: 41522112 [PubMed]
	Perioperative outcomes and survival of indocyanine green-guided minimally esophagectomy in patients with esophageal cancer: a retrospective comparison study. Quant Imaging Med Surg Shen X, Cai Y, Xu Z, Yu P, Bhatti MZ, Chen S, Zhan C, Chen T, Zhu H, Zheng L. PMID: 41522083 [PubMed]
	Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno-carcinoma after perioperative chemotherapy and radical resection. Acta Oncol Larsen AC, Shim S, Bæksgaard L, Pfeiffer P, Nordsmark M, Sørensen JR, Brøndum R, Motavaf AK, Ladekarl M. PMID: 41521569 [PubMed - indexed for MEDLINE]
	Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer. Hum Vaccin Immunother Yan C, He J, Lv G, Gao Y, Li J, Diao R. PMID: 41521567 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Preoperative Short-Term Nutrition and Exercise Trial Program for Patients with Esophageal Cancer: A Randomized Clinical Trial. Ann Surg Oncol Kawata S, Hiramatsu Y, Honke J, Takashima S, Shirai Y, Shibata Y, Sakai Y, Haneda R, Soneda W, Murakami T, Booka E, Matsumoto T, Morita Y, Kikuchi H, Yamauchi K, Takeuchi H. PMID: 41521370 [PubMed - as supplied by publisher]
	Gaining New Ground: The Evolving Role of Radiation Therapy in Esophageal Cancer. Int J Radiat Oncol Biol Phys Miller ED, Ashman JB, Barry A, Jethwa KR, Kim H, Tao R, Wojcieszynski AP, Chuong MD. PMID: 41520890 [PubMed - as supplied by publisher]
	Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma. Int J Mol Sci Momma T, Saito M, Nakajima S, Saito K, Machida E, Miyabe K, Sato Y, Hanayama H, Okayama H, Saze Z, Mimura K, Tsuchiya N, Goto A, Shiraishi K, Kono K. PMID: 41516212 [PubMed - indexed for MEDLINE]
	Three-Year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Neoadjuvant Chemoradiotherapy in Resectable Esophageal Cancer: A Multicenter Retrospective Study. Cancers (Basel) Deng S, Yan X, Peng Y, Zhu L, Shen Y, Ying W, Xu Y, Fu Z. PMID: 41514663 [PubMed]
	CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial. BMJ Open Dai R, Zhang P, Cheng M, Bi F, Zhou J, Liu M. PMID: 41513419 [PubMed - indexed for MEDLINE]
	Symptom clusters in oesophageal cancer patients during varying phases of postoperative chemotherapy: a scoping review. BMJ Open Zhi Q, Liao Y, Ke H, Wang H, Zhan Y, Wang W, Li W, Liu Y, Yu J. PMID: 41513418 [PubMed - indexed for MEDLINE]
	Feasibility of ensuring surgical margins of transoral robotic surgery for lateral oropharyngectomy for p16-positive oropharyngeal squamous cell carcinoma patients compared with non-robotic surgery: A single-center, retrospective study. Auris Nasus Larynx Omura G, Eguchi K, Sakai T, Ito T, Tanaka A, Katoh M, Maezumi S, Murayama Y, Kuroyanagi H, Villar PMAC, Sakai A, Takahashi H, Fushimi C, Mori T, Yoshimoto S. PMID: 41512815 [PubMed - as supplied by publisher]
	The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation. EBioMedicine Dillman A, An H, Huang Z, Chan WC, Blagden S, Parsaeian M, Atkins JR, Smith-Byrne K, Travis RC. PMID: 41512676 [PubMed - as supplied by publisher]
	Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies. Clin Transl Oncol Wu XW, Du Y, Jiao Y. PMID: 41507459 [PubMed - as supplied by publisher]
	Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction. J Obes Metab Syndr Lim JS, Kim S, Cho IY, Shin DW. PMID: 41506747 [PubMed - as supplied by publisher]
	Efficacy and Safety of Anti-PD-(L)1 Treatments: A Systematic Review and Meta-Analysis of Asian vs Non-Asian Patients with Esophageal Squamous Cell Carcinoma. Gastro Hep Adv Ajani J, Zhan L, Kadva A, Kato K, Kretz J, Pietrantonio F, Kelly RJ, Zhang X, Lorenzen S. PMID: 41502852 [PubMed]
	Targeting Esophageal Cancer: Promising Drugs for the Clinical Landscape and Key Knowledge Gaps. Drug Des Devel Ther Akumaga T, Park H, Lockhart AC, Jin RU. PMID: 41502549 [PubMed - indexed for MEDLINE]
	Effects of Î²-hydroxy-Î²-methylbutyrate on skeletal muscle loss in a mouse model of esophageal squamous cell carcinoma. Ann Transl Med Yamamoto M, Koyanagi K, Nishi T, Kazuno A, Shoji Y, Ninomiya Y, Kanamori K, Tajima K, Nakashima R, Mori M. PMID: 41502437 [PubMed]

Artikel 1 - 20 / 38026

Seite 1 von 1902



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung